Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
CEO: Junheng Xie. Company website
Aimei Health Technology Co., Ltd (AFJK) trades at $12.89, down 51.70% on the day, as of Sep 20, 2026 14:59 UTC.
Aimei Health Technology Co., Ltd has a market capitalisation of $78.91M, calculated from the live AFJK share price and shares outstanding.
AFJK trades at a trailing P/E of 64.45, from earnings per share of $0.20 over the last twelve months.
Aimei Health Technology Co., Ltd generated revenue of $0.00 over the trailing twelve months.
AFJK has traded between $12.48 and $85.00 over the past 52 weeks, and the last price is 84.8% below that high.
Yes. Aimei Health Technology Co., Ltd keeps 0.00% of revenue as net income over the trailing twelve months.
Aimei Health Technology Co., Ltd is classified under the Financial Services sector and the Shell Companies industry, and is domiciled in US .
Junheng Xie is the chief executive of Aimei Health Technology Co., Ltd, which employs 2 people.
QFI Terminal shows AFJK with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open AFJK in Terminal See plans